A prospective study of efficacy and safety of once-daily saquinavir/ritonavir plus two nucleoside reverse transcriptase inhibitors in treatment-naive Thai patients. [electronic resource]
Producer: 20051115Description: 761-7 p. digitalISSN:- 1359-6535
- Adult
- Anti-HIV Agents -- administration & dosage
- Antiretroviral Therapy, Highly Active -- adverse effects
- CD4 Lymphocyte Count
- Drug Therapy, Combination
- Female
- HIV Infections -- drug therapy
- HIV-1 -- drug effects
- Humans
- Male
- Prospective Studies
- RNA, Viral -- blood
- Reverse Transcriptase Inhibitors -- administration & dosage
- Ritonavir -- administration & dosage
- Saquinavir -- administration & dosage
- Thailand
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.